Oasis Tears Pf

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation associated with dryness of the eye. It is also indicated for the temporary relief of discomfort resulting from minor irritations of the eye, including those caused by exposure to wind or sun. Additionally, this drug serves as a protectant against further irritation and aids in relieving dryness of the eye.

Dosage and Administration

Healthcare professionals are advised to instill 1 or 2 drops of the medication in the affected eye(s) as needed. The frequency of administration should be determined based on the clinical condition of the patient and the response to treatment. It is important to ensure that the drops are administered in a sterile manner to prevent contamination.

Contraindications

Use of this product is contraindicated in the following situations:

• If the solution changes color or becomes cloudy, as this may indicate a loss of efficacy or safety.

• In individuals with known sensitivity to any ingredient in this product, due to the potential for adverse reactions.

Warnings and Precautions

For external use only. The product should not be utilized if the solution exhibits any changes in color or becomes cloudy, as this may indicate degradation or contamination. Additionally, individuals with known sensitivities to any ingredient in this formulation should refrain from use to avoid adverse reactions.

Healthcare professionals should advise patients to discontinue use and seek medical attention if they experience any of the following symptoms: eye pain, changes in vision, persistent redness or irritation of the eye, or if the condition does not improve or worsens after 72 hours.

It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware of several important safety considerations. The product is intended for external use only. It should not be used if the solution changes color or becomes cloudy, or if the patient is sensitive to any ingredient in the formulation.

During use, it is crucial to avoid contamination by not touching the tip of the container to any surface. Patients are advised to replace the cap after each use and to discard the product 90 days after opening to ensure safety and efficacy.

Patients should discontinue use and consult a healthcare professional if they experience any of the following: eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Oasis Tears Pf (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of Oasis Tears PF Preservative-Free Lubricant Eye Drops during pregnancy. As such, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to exercise caution and consult relevant clinical guidelines when making treatment decisions for pregnant patients.

Lactation

Lactating mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any suspected overdosage to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to monitor the solution for any changes in color or clarity, as these may indicate a problem with the product. It is important to discuss any known sensitivities to the ingredients in the product, as this may affect their ability to use it safely.

Healthcare providers should counsel patients to report any symptoms such as eye pain, changes in vision, or persistent redness or irritation of the eye. Patients should be advised to seek medical attention if their condition worsens or does not improve within 72 hours.

To prevent contamination, patients should be instructed not to touch the tip of the container to any surface. They should also be reminded to replace the cap securely after each use. Additionally, inform patients that the product should be discarded 90 days after opening to ensure safety and efficacy.

Storage and Handling

The product is supplied in packaging that ensures its integrity during storage and handling. It must be protected from light and freezing conditions to maintain its efficacy. The recommended storage temperature range is between 41°F (5°C) and 77°F (25°C). Care should be taken to adhere to these conditions to ensure optimal product performance.

Additional Clinical Information

The route of administration for the medication is ophthalmic. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Oasis Tears Pf, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)